NDC Package 71571-333-24 Eysuvis

Loteprednol Etabonate Suspension/ Drops Ophthalmic - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71571-333-24
Package Description:
2.4 mL in 1 BOTTLE, DROPPER
Product Code:
Proprietary Name:
Eysuvis
Non-Proprietary Name:
Loteprednol Etabonate
Substance Name:
Loteprednol Etabonate
Usage Information:
This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Loteprednol belongs to a class of drugs known as corticosteroids.
11-Digit NDC Billing Format:
71571033324
NDC to RxNorm Crosswalk:
  • RxCUI: 2464838 - loteprednol etabonate 0.25 % Ophthalmic Suspension
  • RxCUI: 2464838 - loteprednol etabonate 2.5 MG/ML Ophthalmic Suspension
  • RxCUI: 2464843 - EYsuVIS 0.25 % Ophthalmic Suspension
  • RxCUI: 2464843 - loteprednol etabonate 2.5 MG/ML Ophthalmic Suspension [Eysuvis]
  • RxCUI: 2464843 - Eysuvis 0.25 % Ophthalmic Suspension
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Alcon Laboratories, Inc.
    Dosage Form:
    Suspension/ Drops - A suspension which is usually administered in a dropwise fashion.
    Administration Route(s):
  • Ophthalmic - Administration to the external eye.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA210933
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    11-18-2020
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    71571-333-011 BOTTLE, DROPPER in 1 CARTON / 1 mL in 1 BOTTLE, DROPPER
    71571-333-831 BOTTLE, DROPPER in 1 CARTON / 8.3 mL in 1 BOTTLE, DROPPER

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71571-333-24?

    The NDC Packaged Code 71571-333-24 is assigned to a package of 2.4 ml in 1 bottle, dropper of Eysuvis, a human prescription drug labeled by Alcon Laboratories, Inc.. The product's dosage form is suspension/ drops and is administered via ophthalmic form.

    Is NDC 71571-333 included in the NDC Directory?

    Yes, Eysuvis with product code 71571-333 is active and included in the NDC Directory. The product was first marketed by Alcon Laboratories, Inc. on November 18, 2020 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 71571-333-24?

    The 11-digit format is 71571033324. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-271571-333-245-4-271571-0333-24